A smartphone-read ultrasensitive and quantitative saliva test for COVID-19.
Sci Adv
; 7(2)2021 01.
Article
in English
| MEDLINE | ID: covidwho-1066788
ABSTRACT
Point-of-care COVID-19 assays that are more sensitive than the current RT-PCR (reverse transcription polymerase chain reaction) gold standard assay are needed to improve disease control efforts. We describe the development of a portable, ultrasensitive saliva-based COVID-19 assay with a 15-min sample-to-answer time that does not require RNA isolation or laboratory equipment. This assay uses CRISPR-Cas12a activity to enhance viral amplicon signal, which is stimulated by the laser diode of a smartphone-based fluorescence microscope device. This device robustly quantified viral load over a broad linear range (1 to 105 copies/µl) and exhibited a limit of detection (0.38 copies/µl) below that of the RT-PCR reference assay. CRISPR-read SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) RNA levels were similar in patient saliva and nasal swabs, and viral loads measured by RT-PCR and the smartphone-read CRISPR assay demonstrated good correlation, supporting the potential use of this portable assay for saliva-based point-of-care COVID-19 diagnosis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Saliva
/
Smartphone
/
Point-of-Care Testing
/
COVID-19 Nucleic Acid Testing
/
COVID-19
Type of study:
Diagnostic study
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
English
Year:
2021
Document Type:
Article
Affiliation country:
Sciadv.abe3703
Similar
MEDLINE
...
LILACS
LIS